PerCP/Cyanine5.5 Anti-Human CD14 Antibody[M5E2]
Cat No.: FCE3452
Size：
| Product Name: | PerCP/Cyanine5.5 Anti-Human CD14 Antibody[M5E2] |
| Cat No.: | FCE3452 |
| host: | Mouse |
| uniprot id: | P08571 |
| geneid: | 929 |
| application: | FCM |
| isotype: | Mouse IgG2a, κ |
| form: | Liquid |
| storage: | This product can be stored at 2-8°C for 12 months. Please protected from prolonged exposure to light and do not freeze. |
| shipping: | Ice bag |
| category id: | Flow Cytometry Antibodies |
| abbreviation: | CD14 |
| conjugation: | PerCP/Cyanine5.5 |
| species reactivity: | Human |
| usage: | Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use. |
| clone no.: | M5E2 |
| background: | CD14 is a 53-55 kD glycosylphosphatidylinositol (GPI)-linked membrane glycoprotein also known as LPS receptor. CD14 is expressed at high levels on monocytes and macrophages, and at lower levels on granulocytes. Some dendritic cell populations such as interfollicular dendritic cells, reticular dendritic cells, and Langerhans cells have also been reported to express CD14. As a high-affinity receptor for LPS, CD14 is involved in the clearance of gram-negative pathogens, and in the upregulation of adhesion molecules and expression of cytokines in monocytes and neutrophils. |
| target synonym: | Monocyte differentiation antigen CD14;CD14;Myeloid cell-specific leucine-rich glycoprotein; |
| concentration: | 5 μL/Test |
| buffer: | Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant. |
| image 1 description: | Human pheripheral blood monocytes are stained with PerCP/Cyanine5.5 Anti-Human CD14 Antibody (filled gray histogram). Unstained pheripheral blood monocytes (blank black histogram) are used as control. |